Wolverine Asset Management’s NRX Pharmaceuticals NRXP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-964
| Closed | -$2.51K | – | 1567 |
|
|
2023
Q3 | $2.51K | Sell |
964
-77
| -7% | -$200 | ﹤0.01% | 1224 |
|
|
2023
Q2 | $5.03K | Sell |
1,041
-73
| -7% | -$353 | ﹤0.01% | 1102 |
|
|
2023
Q1 | $7.34K | Sell |
1,114
-469
| -30% | -$3.09K | ﹤0.01% | 1150 |
|
|
2022
Q4 | $17.6K | Sell |
1,583
-844
| -35% | -$9.37K | ﹤0.01% | 1172 |
|
|
2022
Q3 | $17K | Sell |
2,427
-374
| -13% | -$2.62K | ﹤0.01% | 1520 |
|
|
2022
Q2 | $16K | Sell |
2,801
-638
| -19% | -$3.64K | ﹤0.01% | 1585 |
|
|
2022
Q1 | $84K | Sell |
3,439
-272
| -7% | -$6.64K | ﹤0.01% | 1140 |
|
|
2021
Q4 | $177K | Sell |
3,711
-546
| -13% | -$26K | ﹤0.01% | 982 |
|
|
2021
Q3 | $394K | Buy |
4,257
+2,308
| +118% | +$214K | ﹤0.01% | 788 |
|
|
2021
Q2 | $226K | Buy |
+1,949
| New | +$226K | ﹤0.01% | 1034 |
|
|
2021
Q1 | – | Sell |
-10
| Closed | -$2K | – | 1927 |
|
|
2020
Q4 | $2K | Buy |
+10
| New | +$2K | ﹤0.01% | 1250 |
|